litlas
Log inCreate account

Zhenping Zhu

Active 1996–2021

56
Papers
18,809
Citations
53
h-index
56
i10-index

Citations

Citations per year for Zhenping Zhu1984: 2 citations1994: 1 citations1996: 1 citations1997: 5 citations1998: 6 citations1999: 12 citations2000: 29 citations2001: 60 citations2002: 121 citations2003: 260 citations2004: 259 citations2005: 287 citations2006: 347 citations2007: 318 citations2008: 321 citations2009: 299 citations2010: 331 citations2011: 332 citations2012: 240 citations2013: 271 citations2014: 185 citations2015: 191 citations2016: 193 citations2017: 174 citations2018: 136 citations2019: 402 citations2020: 399 citations2021: 362 citations2022: 300 citations2023: 207 citations2024: 269 citations2025: 121 citations2026: 3 citations1985–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,564 citing papers, 32.9% of this breakdownChina: 855 citing papers, 11% of this breakdownGermany: 514 citing papers, 6.6% of this breakdownUnited Kingdom: 396 citing papers, 5.1% of this breakdownItaly: 360 citing papers, 4.6% of this breakdownJapan: 333 citing papers, 4.3% of this breakdownCanada: 270 citing papers, 3.5% of this breakdownFrance: 236 citing papers, 3% of this breakdownSwitzerland: 201 citing papers, 2.6% of this breakdownAustralia: 183 citing papers, 2.3% of this breakdownNetherlands: 161 citing papers, 2.1% of this breakdownSweden: 145 citing papers, 1.8% of this breakdown
0%32.9%Other 20.2%

Institutions

Fields

  • Medicine49.6%
  • Biochemistry, Genetics and Molecular Biology37.5%
  • Immunology and Microbiology7.1%
  • Neuroscience2%
  • Engineering1.1%
  • Materials Science0.9%
  • Other1.8%

Topics

  • Angiogenesis and VEGF in Cancer9%
  • Cancer Cells and Metastasis4.7%
  • Cancer, Hypoxia, and Metabolism4.2%
  • Immune cells in cancer3.1%
  • Mesenchymal stem cell research2.9%
  • Monoclonal and Polyclonal Antibodies Research2.2%
  • Other73.9%

Coauthors

All papers

Open in search
  1. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    Authors: Rosandra N. Kaplan, Rebecca D. Riba, Stergios Zacharoulis, Anna H. Bramley, Loı̈c Vincent, Carla Costa, Daniel D. MacDonald, David Jin, Koji Shido, Scott Kerns, Zhenping Zhu, Daniel J. Hicklin, Yan Wu, Jeffrey L. Port, Nasser K. Altorki, Elisa Port, Davide Ruggero, Sergey V. Shmelkov, Kristian K. Jensen, Shahin Rafii, David Lyden - Nature 2005 cited by 3,260

  2. An efficient route to human bispecific IgG

    Authors: A. Margaret Merchant, Zhenping Zhu, Jean Q. Yuan, Audrey D. Goddard, Camellia Adams, Leonard G. Presta, Paul Carter - Nature Biotechnology 1998 cited by 509

  3. Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial Cells

    Authors: Andrea T. Hooper, Jason M. Butler, Daniel J. Nolan, Andrea Kranz, Kaoruko Iida, Mariko Kobayashi, Hans‐Georg Kopp, Koji Shido, Isabelle Petit, Kilangsungla Yanger, Daylon James, Larry Witte, Zhenping Zhu, Yan Wu, Bronislaw Pytowski, Zev Rosenwaks, Vivek Mittal, Thomas N. Sato, Shahin Rafii - Cell stem cell 2009 cited by 635

  4. Hypoxia-Independent Angiogenesis in Adipose Tissues during Cold Acclimation

    Authors: Yuan Xue, Nataša Petrovič, Renhai Cao, Ola Larsson, Sharon Lim, Shaohua Chen, Helena M. Feldmann, Zicai Liang, Zhenping Zhu, Jan Nedergaard, Barbara Cannon, Yihai Cao - Cell Metabolism 2009 cited by 385

  5. Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1

    Authors: Chris Folkins, Yuval Shaked, Shan Man, Terence Tang, Christina R. Lee, Zhenping Zhu, Robert M. Hoffman, Robert S. Kerbel - Cancer Research 2009 cited by 372

  6. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors

    Authors: Mario Peichev, Afzal J. Naiyer, Daniel Peixoto Pereira, Zhenping Zhu, William J. Lane, Mathew Williams, Mehmet Oz, Daniel J. Hicklin, Larry Witte, Malcolm A.S. Moore, Shahin Rafii - Blood 2000 cited by 2,261

  7. Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver

    Authors: Tao Zeng, Cuili Zhang, Ning Zhao, Min-Jie Guan, Mo Xiao, Rui Yang, Xiulan Zhao, Li-hua Yu, Zhenping Zhu, Keqin Xie - Redox Biology 2017 cited by 113

  8. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

    Authors: David Lyden, Koichi Hattori, Sérgio Dias, Carla Costa, Pamela Blaikie, Linda Butros, Amy Chadburn, Beate Heissig, Willy Marks, Larry Witte, Yan Wu, Daniel J. Hicklin, Zhenping Zhu, Neil R. Hackett, Ronald G. Crystal, Malcolm A.S. Moore, Katherine A. Hajjar, Katia Manova, Robert Benezra, Shahin Rafii - Nature Medicine 2001 cited by 1,852

  9. Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats

    Authors: Jieli Chen, Zheng Gang Zhang, Yi Li, Lei Wang, Yong Xu, Subhash C. Gautam, Mei Lü, Zhenping Zhu, Michael Chopp - Circulation Research 2003 cited by 648

  10. Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension

    Authors: Mark Toshner, Robert Voswinckel, Mark Southwood, Rafia S. Al‐Lamki, Luke Howard, Denis Marchesan, Jun Yang, Jay Suntharalingam, Elaine Soon, Andrew Exley, Susan Stewart, Markus Hecker, Zhenping Zhu, Ursula M. Gehling, Werner Seeger, Joanna Pepke‐Żaba, Nicholas W. Morrell - American Journal of Respiratory and Critical Care Medicine 2009 cited by 232

  11. Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition

    Authors: Changling Gu, Haixia Zhu, Lan Deng, Xiaoqing Meng, Kai Li, Wei Xu, Le Zhao, Yueqin Liu, Zhenping Zhu, Haomin Huang - Acta Pharmacologica Sinica 2021 cited by 49

  12. Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing

    Authors: Li Li, Lan Deng, Xiaoqing Meng, Changling Gu, Meng Li, Kai Li, Xuesai Zhang, Yun Meng, Wei Xu, Le Zhao, Jianhe Chen, Zhenping Zhu, Haomin Huang - Translational Oncology 2020 cited by 33

  13. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

    Authors: David Jin, Koji Shido, Hans‐Georg Kopp, Isabelle Petit, Sergey V. Shmelkov, Lauren M. Young, Andrea T. Hooper, Hideki Amano, Scott T. Avecilla, Beate Heissig, Koichi Hattori, Fan Zhang, Daniel J. Hicklin, Yan Wu, Zhenping Zhu, Ashley R. Dunn, Hassan Salari, Zena Werb, Neil R. Hackett, Ronald G. Crystal, David Lyden, Shahin Rafii - Nature Medicine 2006 cited by 639

  14. Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils

    Authors: Yuichi Ohki, Beate Heissig, Yayoi Sato, Haruyo Akiyama, Zhenping Zhu, Daniel J. Hicklin, Kazunori Shimada, Hideoki Ogawa, Hiroyuki Daida, Koichi Hattori, Akimichi Ohsaka - The FASEB Journal 2005 cited by 247

  15. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies

    Authors: Seth A. Ettenberg, Olga Charlat, Mike Daley, Shanming Liu, Karen J. Vincent, Darrin D. Stuart, Alwin G. Schuller, Jing Yuan, Beatriz Muñoz, John Green, Qunyan Yu, Renee Walsh, Sharon Li, Rita Schmitz, Holger Heine, Sanela Bilic, Lance Ostrom, Rebecca Mosher, K. Felix Hartlepp, Zhenping Zhu, Stephen E. Fawell, Yung‐Mae Yao, David R. Stover, Peter M. Finan, Jeffery A. Porter, William R. Sellers, Ingo M. Klagge, Feng Cong - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 153

  16. Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells

    Authors: Jacinta Serpa, Francisco Caiado, Tânia Carvalho, Cheila Torre, Luís G. Gonçalves, Cristina Casalou, Pedro Lamosa, Margarida Rodrigues, Zhenping Zhu, Eric W.‐F. Lam, Sérgio Dias - Journal of Biological Chemistry 2010 cited by 86

  17. Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells

    Authors: Koichi Hattori, Sérgio Dias, Beate Heissig, Neil R. Hackett, David Lyden, Masatoshi Tateno, Daniel J. Hicklin, Zhenping Zhu, Larry Witte, Ronald G. Crystal, Malcolm A.S. Moore, Shahin Rafii - The Journal of Experimental Medicine 2001 cited by 688

  18. Nitric Oxide Enhances Angiogenesis via the Synthesis of Vascular Endothelial Growth Factor and cGMP After Stroke in the Rat

    Authors: Ruilan Zhang, Lei Wang, Zhang Li, Jieli Chen, Zhenping Zhu, Zhenggang Zhang, Michael Chopp - Circulation Research 2003 cited by 298

  19. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis

    Authors: Ruolin Guo, Quan Zhou, Steven T. Proulx, Ronald W. Wood, Rui‐Cheng Ji, Christopher T. Ritchlin, Bronislaw Pytowski, Zhenping Zhu, Yongjun Wang, Edward M. Schwarz, Lianping Xing - Arthritis & Rheumatism 2009 cited by 172

  20. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy

    Authors: Dan Lü, Xenia Jimenez, Haifan Zhang, Peter Böhlen, Larry Witte, Zhenping Zhu - International Journal of Cancer 2001 cited by 137

  21. The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress

    Authors: Tao Zeng, Cuili Zhang, Fuyong Song, Xiulan Zhao, Li-hua Yu, Zhenping Zhu, Keqin Xie - Biochimica et Biophysica Acta (BBA) - General Subjects 2013 cited by 118

  22. VEGFR1–mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy

    Authors: Renhai Cao, Yuan Xue, Eva–Maria Hedlund, Zhaodong Zhong, Katerina Tritsaris, Barbara Tondelli, Franco Lucchini, Zhenping Zhu, Steen Dissing, Yihai Cao - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 111

  23. Research and development of next generation of antibody-based therapeutics

    Authors: Jing Li, Zhenping Zhu - Acta Pharmacologica Sinica 2010 cited by 131

  24. Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

    Authors: Zhaojing Zhong, Kyla Driscoll Carroll, Desiree Policarpio, Carla Osborn, Michael Gregory, Rajiv Bassi, Xenia Jimenez, Marie Prewett, Gregory Liebisch, Kris Persaud, Douglas Burtrum, Su Wang, David Surguladze, Stanley S. Ng, Heather Griffith, Paul Balderes, Jacqueline Doody, Jonathan D. Schwartz, Hagop Youssoufian, Eric K. Rowinsky, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Yan Wu - Clinical Cancer Research 2010 cited by 124